Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
In biological research, especially in areas such a
The Nobel Prize in Physiology or Medicine awarded
India is one of the largest centers of global phar
By the end of 2025, the pharma, laboratory, and an
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Micro
AstraZeneca said on Tuesday it began early stage trials to get an antibody-based treatment for the prevention and treatment of COVID-19, as the British drugmaker also ploughs on with its vaccine candidate.
The trial will assess if AZD7442, a blend of two monoclonal antibodies, is tolerable and safe in up to 48 healthy participants between the ages of 18 and 55 years in the uk together with the backing of the USA.
